Jeroen Jansen, PhD, lead scientific advisor, Open-Source Value Project, Innovation and Value Initiative, discusses challenges with incorporating more novel concepts of value into value assessment.
Jeroen Jansen, PhD, lead scientific advisor, Open-Source Value Project, Innovation and Value Initiative, discusses challenges with incorporating more novel concepts of value into value assessment.
Transcript
What challenges are there with incorporating more novel concepts of value into value assessment?
That’s an interesting question. Traditionally, a lot of the value assessment is done in what’s called a cost-effectiveness analysis framework where we calculate the expected costs and the expected risks and benefits for the patients. But now, there’s a discussion like what novel elements need to be incorporated. For example, one of the novel elements is what’s called “value of hope,” which means that even if on the average, 2 interventions give you the same benefits, it might be that one of the interventions has more variation in how individual patients may respond versus the other intervention. It might be that certain patients prefer the intervention where you see more variation in response because they might be the lucky ones to respond much better than the simple average. That’s currently, for example, overlooked.
Another component, one of the other novel elements, is something that’s called insurance value, where we say currently, value assessment is all about how can we optimize treatment allocation given the budgets we have to work with. But, the value of an intervention goes beyond the individuals patients. For example, if we have a new efficacious treatment for example for Alzheimer, that benefits everyone of us that is potentially at risk for Alzheimer disease.
Overcoming Employment Barriers for Lasting Social Impact: Freedom House 2.0 and Pathways to Work
April 16th 2024To help celebrate and recognize National Minority Health Month, we are bringing you a special month-long podcast series with our Strategic Alliance Partner, UPMC Health Plan. Welcome to our second episode, in which we learn all about Freedom House 2.0 and the Pathways to Work program.
Listen
Dr Michael Farwell on FDG PET/CT Imaging to Predict Immunotherapy Response in Advanced Melanoma
April 15th 2024Michael Farwell, MD, associate professor of radiology at the Hospital of the University of Pennsylvania, provides insights into a study on the benefits of using 18F-fluorodeoxyglucose (FDG) PET/CT imaging to detect metabolic tumor changes in skin cancer.
Read More
Making Giant Strides in Maternity Health Through Baby Steps
April 9th 2024To help celebrate and recognize National Minority Health Month, we are kicking off a special month-long podcast series with our strategic alliance partner, UPMC Health Plan. Welcome to our first episode, which is all about the Baby Steps Maternity Program and its mission to support women throughout every step of their pregnancy journey.
Listen
Increasing Lp(a) Awareness for Better Cardiovascular Health: Dr Mary McGowan
March 24th 2024For Lp(a) Awareness Day, Mary McGowan, MD, FNLA, chief medical officer of the Family Heart Foundation, highlights how most people with elevated Lp(a) are completely unaware that they have this increased risk and calls for increased testing.
Read More
Dr Al Benson on Reimbursement for Supportive Care When Treating Patients With Cancer
March 22nd 2024Al Benson, MD, FACP, FACCC, FASCO, medical oncologist at Northwestern University Feinberg School of Medicine and associate director of the Robert E. Tillery Comprehensive Cancer Center, discussed findings from a national survey assessing barriers to comprehensive cancer care delivery.
Read More